Cite
HARVARD Citation
Yu, W. et al. (2022). Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure. Pulmonary circulation. p. n/a. [Online].